Share:
Peer-Reviewed Publication
Europace2023;26(1)December 28, 2023Journal Article

Improved diagnostic performance of insertable cardiac monitors by an artificial intelligence-based algorithm.

Eliot Crespin1, Arnaud Rosier1,2, Issam Ibnouhsein1, Alexandre Gozlan1, Arnaud Lazarus3, Gabriel Laurent4, Aymeric Menet5, Jean-Luc Bonnet1, Niraj Varma6
1Implicity SAS, Paris, France.
2Jacques Cartier Private Hospital, Massy, France.
3Service de rythmologie interventionnelle, Clinique Ambroise Paré, Neuilly sur Seine, France.
4Service de rythmologie et Insuffisance Cardiaque, Centre Hospitalier Universitaire, Dijon, France.
5Département de Cardiologie, Groupe Hospitalier de l'Institut Catholique de Lille, Lomme, France.
6Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

Abstract

AIMS: The increasing use of insertable cardiac monitors (ICM) produces a high rate of false positive (FP) diagnoses. Their verification results in a high workload for caregivers. We evaluated the performance of an artificial intelligence (AI)-based ILR-ECG Analyzer™ (ILR-ECG-A). This machine-learning algorithm reclassifies ICM-transmitted events to minimize the rate of FP diagnoses, while preservi…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.